Institut Biophytis SAS (ALBPS)

Paris


	Symbol		Exchange		Currency
	ALBPS		Paris		EUR	Real-time
	BPTSY		OTC Markets		USD	Delayed

Currency in EUR

0.3098

+0.0027(+0.00%)

Closed06/12

Fair Value

Day's Range

0.3000

0.3150

52 wk Range

0.2800

3.5200

ALBPS Income Statement

Explore the detailed Institut Biophytis SAS income statement, offering a comprehensive view of the company’s financial performance. Review essential metrics such as revenue, gross profit, operating income, and net income over selected periods. This page provides a clear breakdown of profitability and operational efficiency, helping you evaluate Institut Biophytis SAS's growth trends and overall financial health.

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

-

-

-

-

-

Total Revenues Growth

-

-

-

-

-

Cost Of Revenues

-

-

-

-

-

Gross Profit

-

-

-

-

-

Gross Profit Growth

-

-

-

-

-

Gross Profit Margin %

-

-

-

-

-

Other Operating Expenses, Total

15.68

13.94

26.82

23.27

14.33

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+13.14%	-11.1%	+92.33%	-13.22%	-38.41%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	9.09	9.92	19.67	16.03	8.85
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	6.59	4.02	7.15	7.24	5.49
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

-15.68

-13.94

-26.82

-23.27

-14.33

Operating Income Growth

-13.14%

+11.1%

-92.33%

+13.22%

+38.41%

EBIT Margin %

-

-

-

-

-

Net Interest Expenses

-1.45

-1.24

-0.65

-1.43

-1.42

Net Interest Expenses Growth

-664.55%

+14.46%

+47.49%

-119.88%

+0.21%

Interest Expense, Total

-1.45

-1.27

-0.67

-2.42

-1.42

Interest And Investment Income

-

0.03

0.02

0.99

-

Other Non Operating Expenses, Total

-1.9

-10.34

-2.01

0.56

-1.27

EBT, Excl. Unusual Items

-19.03

-25.52

-29.47

-24.14

-17.03

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

-

-

-1.7

-0.08

-

EBT, Incl. Unusual Items

-19.03

-25.52

-31.16

-24.22

-17.03

EBT, Incl. Unusual Items Growth

-35.33%

-34.12%

-22.13%

+22.29%

+29.69%

EBT, Incl. Unusual Items Margin

-

-

-

-

-

Income Tax Expense

-0.08

-

-

-

-

Net Income to Company

-18.95

-25.52

-31.16

-24.22

-17.03

Minority Interest

-

-

0

-

-

Net Income

-18.95

-25.52

-31.16

-24.22

-17.03

Net Income Growth

-35.45%

-34.68%

-22.13%

+22.29%

+29.69%

Net Income Margin %

-

-

-

-

-

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

-18.95

-25.52

-31.16

-24.22

-17.03

Basic EPS - Continuing Operations

-448.88

-170.19

-105.38

-55.4

-12.54

Basic EPS - Continuing Operations Growth

-7.31%

+62.09%

+38.08%

+47.43%

+77.36%

Diluted EPS - Continuing Operations

-448.88

-172

-105.38

-56

-12.54

Diluted EPS - Continuing Operations Growth

-6.88%

+61.68%

+38.73%

+46.86%

+77.61%

Basic Weighted Average Shares Outstanding

0.04

0.15

0.3

0.44

1.36

Diluted Weighted Average Shares Outstanding

0.04

0.15

0.3

0.44

1.36

Dividend Per Share

-

-

-

-

-

Dividend Per Share Growth

-

-

-

-

-

EBITDA

-15.42

-13.66

-26.5

-23.04

-13.8

EBITDA Growth

-13.1%

+11.4%

-94%

+13.07%

+40.08%

EBITDA Margin %